Netarsudil-Associated Reticular Epithelial Edema Directly Influenced by Endothelial Dysfunction in a Post-Endothelial Keratoplasty Patient

Abstract

The purpose of this report was to describe a case in which reticular epithelial edema secondary to topical netarsudil ophthalmic solution 0.2% occurred directly in relation to focal endothelial dysfunction in a post-endothelial keratoplasty eye. This was a case report. A 76-year-old man with a complex ocular history was diagnosed with pseudophakic bullous keratopathy of the left eye. Topical netarsudil was prescribed to treat his glaucoma and to attempt improvement of his corneal edema. The corneal examination remained stable for many months, but the patient eventually underwent a Descemet stripping automated endothelial keratoplasty (DSAEK) for worsening corneal edema. One week later, the patient was observed to have 360-degree reticular epithelial edema around the periphery of the DSAEK graft. Given the lack of visual significance and need for continued glaucoma treatment, the patient was continued on netarsudil. The reticular epithelial edema later became restricted to areas outside the graft zone as the peripheral DSAEK graft endothelial cell function improved. Two months post-DSAEK, the patient developed a partial inferior endothelial graft rejection related to inadvertent cessation of topical steroid, with keratic precipitates, stromal edema, and new overlying reticular epithelial edema. On treatment and resolution of the DSAEK graft rejection, the overlying reticular epithelial edema also resolved. This case clearly demonstrates that netarsudil-associated reticular epithelial edema is highly likely to be related to endothelial cell dysfunction and that if endothelial cell dysfunction improves, the reticular epithelial edema will also improve, despite the continuation of netarsudil.